About: High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China
Creator	Liu, Na Hong, Yan Chen, Ren-Gui Zhu, Heng-Mei
Source	MedRxiv
abstract	Background: 2019 Novel coronavirus disease (COVID-19) is turning into a pandemic globally lately. Angiotensin-converting enzyme 2 (ACE2) is identified as an important functional receptor for SARS-Cov-2. ACE2 and ACE are homologues with inverse functions in the renin-angiotensin system. ACE converts angiotensin I into a vital vasoactive peptide called angiotensin II(AngII), whereas ACE2 hydrolyzes AngII into a series of vasodilators. There were few reports illustrated the expression of AngII in COVID-19. This study aimed to demonstrate the expression of angiotensin II in COVID-19 and how it correlated to the disease. Methods: We enrolled 55 patients with COVID-19 admitted to renmin Hospital of Wuhan University from January 21st to February 21st, 2020. Demographic data were collected upon admission. COVID-19 nuclear acid, plasma AngII, Renin and aldosterone in the lying position without sodium restriction, and other laboratory indicators were together measured by the laboratory department of our hospital. Findings: Of the 55 patients with COVID-19, 34(61.8%) had an increased level of AngII. The severity of COVID-19 and male is positively related with the level of AngII. The level of blood lymphocyte, PCT, ALT, and AST were remarkably severe with those of normal level of AngII (P < 0.05). CD4/CD8 cells ratio was significantly higher whereas CD3+CD8+ cells amount, CD3+CD8+ cells proportion, CD56+CD16+CD3- cells amount and CD19+CD3- cells amount were considerably lower than those of normal level of AngII (P < 0.05). Abnormal rates of blood lymphocyte and PCT were significantly higher in Patients with elevated AngII level. The results of binary logistic regression analysis showed that the severity of COVID-19 (OR=4.123) and CD4/CD8 ratio(OR=4.050) were the co-directional impact factor while female(OR=0.146) was inverse impact factor of elevated AngII level. Interpretation: High rate of increased level of AngII was detected in COVID-19 patients. Patients with elevated AngII level were more likely to be critically ill with COVID-19. Considering the gender differences in ACE2 expression and no gender differences in angiotensin expression, the gender differences in AngII level might indicate less loss of ACE2 in female patients. Elevated AngII level was correlated with CD4/CD8 ratio, suggesting it might involve in immune disorder. Keywords: 2019 Novel coronavirus disease(COVID-19), Angiotensin-converting enzyme 2 (ACE2), Angiotensin II(AngII), gender differences
has issue date	2020-05-01(xsd:dateTime)
bibo:doi	10.1101/2020.04.27.20080432
has license	medrxiv
sha1sum (hex)	cd0d59e1e1b0c99da6a50e331fa04385988a1a33
schema:url	https://doi.org/10.1101/2020.04.27.20080432
resource representing a document's title	High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China
resource representing a document's body	covid:cd0d59e1e1b0c99da6a50e331fa04385988a1a33#body_text
is schema:about of	named entity 'China' named entity 'COVID-19' named entity 'hospital' named entity 'single hospital' named entity 'WuHan' named entity 'COVID-19' named entity 'COVID-19' named entity 'data analysis' named entity 'ACE2' named entity 'dopamine' named entity 'vasoactive' named entity 'COVID-19' named entity 'CD3+CD8+' named entity 'CD8' named entity 'plasma' named entity 'angiotensin-converting enzyme (ACE) inhibitors' named entity 'medRxiv' named entity 'renin' named entity 'Mann-Whitney U test' named entity 'preprint' named entity 'plasma' named entity 'renin' named entity 'medRxiv' named entity 'COVID-19' named entity 'risk factor' named entity 'hypertension' named entity 'preprint' named entity 'epidemiological' named entity 'C-reactive protein' named entity 'renin' named entity 'sodium' named entity 'peer review' named entity 'vasoactive' named entity 'immune disorder' named entity 'vs5' named entity 'Ang II' named entity 'negative regulator' named entity 'COVID-19 outbreak' named entity 'Wuhan University' named entity 'preprint' named entity 'blood chemistry' named entity 'norepinephrine' named entity 'sodium' named entity 'ACE' named entity 'preprint' named entity 'statistical difference' named entity 'aldosterone' named entity 'COVID-19' named entity 'lactate dehydrogenase' named entity 'Ang II' named entity 'COVID-19' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'procalcitonin' named entity 'Ang II' named entity 'Ang II' named entity 'preprint' named entity 'peer review' named entity 'single center' named entity 'angiotensin II' named entity 'hypertension' named entity 'aldosterone' named entity 'ACE2' named entity 'peer review' named entity 'Ang II' named entity 'COVID-19' named entity 'preprint' named entity 'CD3+CD8+' named entity 'vasoactive' named entity 'significant difference' named entity 'angiotensin II' named entity 'hypertension' named entity 'peer review' named entity 'preprint' named entity 'chromosome' named entity 'aldosterone' named entity 'SPSS' named entity 'coagulation' named entity 'standard deviations' named entity 'hypertension' named entity 'COVID-19' named entity 'CD4'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software